Navigation Links
Stroke Rehab Technique Has Lasting Results

Constraint-induced movement therapy improves strength and quality of life, researchers say

TUESDAY, Dec. 11 (HealthDay News) -- With just two weeks of so-called constraint-induced movement therapy, some stroke patients can have significant improvement in the functioning of their affected hand and a better quality of life, a new study finds.

For the study, participants wore a mitt on the less-affected hand. This forced them to use their affected hand while doing a repetitive task -- such as grooming or eating -- with the hope of improving the use of their hand and rebuilding strength. The mitt was worn for most of their waking hours for two weeks.

"The folks who have extremity constraint-induced movement therapy have significant improvements in the use of their impaired upper extremity that persist after two weeks of training," said lead researcher Steven Wolf, a professor of rehabilitation medicine at Emory University School of Medicine.

The researchers found that these gains were still evident two years later. "Over two years, strength-based measures improved further, and many measures of quality of life improved substantially," Wolf said.

The report was published online Dec. 11 in The Lancet Neurology.

In the EXCITE (extremity constraint-induced movement therapy evaluation) trial, 106 patients were randomly assigned to extremity constraint-induced movement therapy or usual therapy, which ranged from no treatment after concluding formal rehabilitation to drugs or continued physiotherapy.

The new study was an extension of the EXCITE trial, which demonstrated that people who underwent extremity constraint-induced therapy had better results in hand function after one year, compared with people who received usual care.

Wolf's team found that two years after treatment, there was no decline in the improvements seen after one year. In fact, the participants continued to gain strength and improvement in ability, the researchers said.

Moreover, quality of life was significantly better two years after treatment. Improvements were seen in social participation, activities of daily living, and overall physical function, Wolf said.

Wolf said the restraint therapy can be used on about 30 percent of stroke patients -- or those with mild to moderate impairment. "People who will benefit are those who can begin to open their hand six weeks after the stroke," he said. "Extremity constraint-induced movement therapy can, over a short period of time, lead to improvements that are sustainable."

One stroke expert thinks the study results are impressive, but more research needs to be done before the technique is adopted widely.

"In stroke rehabilitation, we don't have a lot of things to offer these folks," said Dr. Michael W. O'Dell, acting chief of rehabilitation medicine at New York-Presbyterian Hospital, Weill Cornell Medical Center in New York City. "It's pretty remarkable that a treatment that was provided for two weeks, two years ago, is still having an effect on people's ability to function on a day-to-day basis."

O'Dell said it's important to note that the patients in the EXCITE trial did have some movement in the affected hand before the study began. "They were not the worst of the worst," he said. "But it's really encouraging that there is some possibility for further recovery."

O'Dell noted there are some drawbacks to extremity constraint-induced therapy. For one, insurance companies and Medicare won't pay for it. "It's too expensive," he said.

Also, the therapy is very frustrating for patients. "So, you have to have an incredibly motivated patient to do this," O'Dell said.

More information

To learn more about stroke, visit the American Stroke Association.

SOURCES: Steven Wolf, Ph.D., professor of rehabilitation medicine, Emory University School of Medicine, Atlanta; Michael W. O'Dell, M.D., acting chief of rehabilitation medicine, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York City; Dec. 11, 2007, The Lancet Neurology, online

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. High alcohol consumption increases stroke risk among Chinese men
3. Heavy Drinking Boosts Stroke Risk for Chinese Men
4. High alcohol consumption increases stroke risk, Tulane study says
5. Broad-based group of physicians calls for improvement in stroke treatment
6. Continued Statin Use Boosts Post-Stroke Outcomes
7. U.S. Initiative Seeks to Boost Hispanic Stroke Awareness
8. Stopping Statins After Stroke Doubles Death Risk
9. Can brain-injured, partially-blind stroke patients regain some of their lost vision?
10. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
11. Link Between Air Pollution, Stroke Gets Clearer
Post Your Comments:
Related Image:
Stroke Rehab Technique Has Lasting Results 
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: